Skip to main content
Top
Published in: Clinical Rheumatology 6/2013

01-06-2013 | Original Article

Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases

Authors: Chan Hee Lee, Na Young Sung, Jisoo Lee, Sang-Cheol Bae

Published in: Clinical Rheumatology | Issue 6/2013

Login to get access

Abstract

The aim of this study was to identify the factors associated with gout among South Koreans. A case control study of gout patients newly diagnosed between January 1, 2007, and December 31, 2008, and matching controls was conducted using the nationwide database (National Health Insurance Corporation and National Health Screening Exam (NHSE) database), which included the health-care records of 48.1 million individuals. Of 495,998 newly diagnosed patients, we included 18,123 who were ≥40 years old and had an NHSE before diagnosis of gout. To elucidate the factors associated with gout, multivariate conditional logistic analyses were performed. Gout was associated with drinking ≥1/week (p < 0.001), drinking ≥1 bottle of soju/session (p < 0.001), high body mass index (BMI) (p < 0.001), high blood pressure (p < 0.001), high total cholesterol (p < 0.001), proteinuria (multivariate odds ratio (OR) = 1.75; 95 % confidence interval (CI) = 1.53–2.00), and an elevated uric acid (multivariate OR = 1.54; 95 % CI = 1.22–1.94). Exercise frequency was not significantly associated with gout. Prediabetic blood sugar level (100–125 mg/dL) was associated with gout in the univariate analysis, but not in the multivariate analysis. Diabetic blood sugar level (≥126 mg/dL) was associated with a decreased odds of gout (multivariate OR = 0.79; 95 % CI = 0.73–0.86). Our nationwide South Korean study showed that frequent and excessive alcohol consumption, high BMI, high blood pressure, high total cholesterol, proteinuria, and high uric acid are associated with gout.
Literature
1.
go back to reference Yoo HG, Lee SI, Chae HJ, Park SJ, Lee YC, Yoo WH (2011) Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. Rheumatol Int 31:485–491PubMedCrossRef Yoo HG, Lee SI, Chae HJ, Park SJ, Lee YC, Yoo WH (2011) Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. Rheumatol Int 31:485–491PubMedCrossRef
2.
go back to reference Choi HK (2010) A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 22:165–172PubMedCrossRef Choi HK (2010) A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 22:165–172PubMedCrossRef
3.
go back to reference Novak S, Melkonian AK, Patel PA, Kleinman NL, Joseph-Ridge N, Brook RA (2007) Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use. Curr Med Res Opin 23:623–630PubMedCrossRef Novak S, Melkonian AK, Patel PA, Kleinman NL, Joseph-Ridge N, Brook RA (2007) Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use. Curr Med Res Opin 23:623–630PubMedCrossRef
4.
go back to reference Perez-Ruiz F, Calabozo M, Herrero-Beites AM, Garcia-Erauskin G, Pijoan JI (2000) Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 86:287–291PubMedCrossRef Perez-Ruiz F, Calabozo M, Herrero-Beites AM, Garcia-Erauskin G, Pijoan JI (2000) Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 86:287–291PubMedCrossRef
5.
go back to reference Shah A, Keenan RT (2010) Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? Curr Rheumatol Rep 12:118–124PubMedCrossRef Shah A, Keenan RT (2010) Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? Curr Rheumatol Rep 12:118–124PubMedCrossRef
6.
go back to reference Gaffo AL, Edwards NL, Saag KG (2009) Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther 11:240PubMedCrossRef Gaffo AL, Edwards NL, Saag KG (2009) Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther 11:240PubMedCrossRef
7.
go back to reference Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403–2406PubMed Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403–2406PubMed
8.
go back to reference Currie WJ (1979) Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 38:101–106PubMedCrossRef Currie WJ (1979) Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 38:101–106PubMedCrossRef
9.
go back to reference Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis 64:267–272PubMedCrossRef Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis 64:267–272PubMedCrossRef
10.
go back to reference Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58:26–35PubMedCrossRef Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58:26–35PubMedCrossRef
11.
go back to reference Annemans L, Spaepen E, Gaskin M et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966PubMedCrossRef Annemans L, Spaepen E, Gaskin M et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966PubMedCrossRef
12.
go back to reference Lee CH, Sung NY (2011) The prevalence and features of Korean gout patients using the National Health Insurance Corporation Database. J Korean Rheum Assoc 18:94–100 Lee CH, Sung NY (2011) The prevalence and features of Korean gout patients using the National Health Insurance Corporation Database. J Korean Rheum Assoc 18:94–100
13.
go back to reference Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57:109–115PubMedCrossRef Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57:109–115PubMedCrossRef
14.
go back to reference Chang HY, Pan WH, Yeh WT, Tsai KS (2001) Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993–96). J Rheumatol 28:1640–1646PubMed Chang HY, Pan WH, Yeh WT, Tsai KS (2001) Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993–96). J Rheumatol 28:1640–1646PubMed
15.
go back to reference Rho YH, Choi SJ, Lee YH et al (2005) The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci 20:1029–1033PubMedCrossRef Rho YH, Choi SJ, Lee YH et al (2005) The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci 20:1029–1033PubMedCrossRef
16.
go back to reference Chung HG, Song JS (2009) 2008 National Health Insurance statistical yearbook. National Health Insurance Corporation, Health Insurance Review & Assessment Service, Seoul Chung HG, Song JS (2009) 2008 National Health Insurance statistical yearbook. National Health Insurance Corporation, Health Insurance Review & Assessment Service, Seoul
17.
go back to reference Korean Society for the Study of Obesity (2009) Obesity treatment guideline, 2009. Chungun Publisher, Seoul Korean Society for the Study of Obesity (2009) Obesity treatment guideline, 2009. Chungun Publisher, Seoul
18.
go back to reference Expert Consultation WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef Expert Consultation WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef
19.
go back to reference Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560–2572PubMedCrossRef Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560–2572PubMedCrossRef
20.
go back to reference American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30:S42–S47CrossRef American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30:S42–S47CrossRef
21.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef
22.
go back to reference Choi HK, Curhan G (2004) Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 51:1023–1029PubMedCrossRef Choi HK, Curhan G (2004) Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 51:1023–1029PubMedCrossRef
23.
go back to reference Gaffo AL, Roseman JM, Jacobs DR Jr et al (2010) Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis 69:1965–1970PubMedCrossRef Gaffo AL, Roseman JM, Jacobs DR Jr et al (2010) Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis 69:1965–1970PubMedCrossRef
24.
go back to reference Koh MJ, Han JT, Lee AK, Kim MK, Park SH (2008) Construction of national health screening examinee cohort—development of the validity test. National Health Insurance Corporation, Seoul Koh MJ, Han JT, Lee AK, Kim MK, Park SH (2008) Construction of national health screening examinee cohort—development of the validity test. National Health Insurance Corporation, Seoul
25.
go back to reference Park IS, Koh MJ, Kim HJ (2009) Construction of national health screening examinee cohort—validity test of National Health Insurance Database (II). National Health Insurance Corporation, Seoul Park IS, Koh MJ, Kim HJ (2009) Construction of national health screening examinee cohort—validity test of National Health Insurance Database (II). National Health Insurance Corporation, Seoul
26.
go back to reference Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, 3rd Miller ER (2005) Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 165:2299–2304PubMedCrossRef Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, 3rd Miller ER (2005) Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 165:2299–2304PubMedCrossRef
27.
go back to reference Lim S, Park KS, Lee HK, Cho SI, Health KN, Surveys NE (2005) Changes in the characteristics of metabolic syndrome in Korea over the period 1998–2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 28:1810–1812PubMedCrossRef Lim S, Park KS, Lee HK, Cho SI, Health KN, Surveys NE (2005) Changes in the characteristics of metabolic syndrome in Korea over the period 1998–2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 28:1810–1812PubMedCrossRef
28.
go back to reference Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277–1281PubMedCrossRef Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277–1281PubMedCrossRef
29.
go back to reference Choi HK, Ford ES (2007) Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120:442–447PubMedCrossRef Choi HK, Ford ES (2007) Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120:442–447PubMedCrossRef
30.
go back to reference Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165:742–748PubMedCrossRef Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165:742–748PubMedCrossRef
31.
go back to reference Kuo CF, See LC, Luo SF et al (2010) Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatol (Oxford) 49:141–146CrossRef Kuo CF, See LC, Luo SF et al (2010) Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatol (Oxford) 49:141–146CrossRef
32.
go back to reference Williams PT (2008) Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 87:1480–1487PubMed Williams PT (2008) Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 87:1480–1487PubMed
33.
go back to reference Zhu Y, Zhang Y, Choi HK (2010) The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatol (Oxford) 49:2391–2399CrossRef Zhu Y, Zhang Y, Choi HK (2010) The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatol (Oxford) 49:2391–2399CrossRef
34.
go back to reference Nan H, Qiao Q, Soderberg S et al (2008) Serum uric acid and incident diabetes in Mauritian Indian and Creole populations. Diabetes Res Clin Pract 80:321–327PubMedCrossRef Nan H, Qiao Q, Soderberg S et al (2008) Serum uric acid and incident diabetes in Mauritian Indian and Creole populations. Diabetes Res Clin Pract 80:321–327PubMedCrossRef
35.
go back to reference Rodriguez G, Soriano LC, Choi HK (2010) Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 69:2090–2094PubMedCrossRef Rodriguez G, Soriano LC, Choi HK (2010) Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 69:2090–2094PubMedCrossRef
36.
go back to reference Cook DG, Shaper AG, Thelle DS, Whitehead TP (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006PubMedCrossRef Cook DG, Shaper AG, Thelle DS, Whitehead TP (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006PubMedCrossRef
37.
go back to reference Choi HK, Ford ES (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels—the Third National Health and Nutrition Examination Survey. Rheumatol (Oxford) 47:713–717CrossRef Choi HK, Ford ES (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels—the Third National Health and Nutrition Examination Survey. Rheumatol (Oxford) 47:713–717CrossRef
38.
go back to reference Jo SY, Park Y, Lee CH (2011) The effect of hypouricemic treatment on the renal function in patients with gout. J Korean Rheum Assoc 18:26–31 Jo SY, Park Y, Lee CH (2011) The effect of hypouricemic treatment on the renal function in patients with gout. J Korean Rheum Assoc 18:26–31
39.
go back to reference Kondo M, Yamagata K, Hoshi SL et al (2012) Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol 16:279–291PubMedCrossRef Kondo M, Yamagata K, Hoshi SL et al (2012) Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol 16:279–291PubMedCrossRef
40.
go back to reference Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y (2006) Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 33:104–109PubMed Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y (2006) Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 33:104–109PubMed
41.
go back to reference McAdams MA, Maynard JW, Baer AN et al (2011) Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol 38:135–141PubMedCrossRef McAdams MA, Maynard JW, Baer AN et al (2011) Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol 38:135–141PubMedCrossRef
42.
go back to reference Park SK, Cheong HK, Ki M, Son YM, Kim H (2003) Assessment of the availability of health insurance data for epidemiologic study of childhood aseptic meningitis. Korean J Prev Med 36:349–358 Park SK, Cheong HK, Ki M, Son YM, Kim H (2003) Assessment of the availability of health insurance data for epidemiologic study of childhood aseptic meningitis. Korean J Prev Med 36:349–358
43.
go back to reference Cheong HK, Park SK, Ki M, Lee K (2008) Six year national trend of childhood aseptic meningitis incidence in Korea, 1996–2001. Korean J Epidemiol 30:252–262CrossRef Cheong HK, Park SK, Ki M, Lee K (2008) Six year national trend of childhood aseptic meningitis incidence in Korea, 1996–2001. Korean J Epidemiol 30:252–262CrossRef
44.
go back to reference Kim J (2008) Diabetes in Korea 2007. In: Korean Diabetes Association, Health Insurance Review & Assessment Service, Task Force Team For Basic Statistical Study of Korean Diabetes Mellitus (ed) Validity of health insurance data, Firstth edn. Goldfishery, Seoul, pp 7–13 Kim J (2008) Diabetes in Korea 2007. In: Korean Diabetes Association, Health Insurance Review & Assessment Service, Task Force Team For Basic Statistical Study of Korean Diabetes Mellitus (ed) Validity of health insurance data, Firstth edn. Goldfishery, Seoul, pp 7–13
45.
go back to reference Park BJ, Sung JH, Park KD, Seo SW, Kim SW (2003) Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance Database. Seoul National University, Seoul Park BJ, Sung JH, Park KD, Seo SW, Kim SW (2003) Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance Database. Seoul National University, Seoul
Metadata
Title
Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases
Authors
Chan Hee Lee
Na Young Sung
Jisoo Lee
Sang-Cheol Bae
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2183-9

Other articles of this Issue 6/2013

Clinical Rheumatology 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.